Matthias Hentze receives Centenary Award
EMBL Heidelberg’s Matthias Hentze receives the Biochemical Society’s Centenary Award for his discoveries in RNA biology.
EMBL ANNOUNCEMENTSLAB MATTERS2022
embl-announcementslab-matters
Blood-clotting protein linked to cancer and septicaemia
In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body’s stress response is to stock-pile blood-clotting factors. Scientists in the Molecular Medicine Partnership Unit (MMPU), a collaboration between the European Molecular…
SCIENCE & TECHNOLOGY2011
sciencescience-technology
Scientists open doors to diagnosis of emphysema
Chronic inflammatory lung diseases like chronic bronchitis and emphysema are a major global health problem, and the fourth leading cause of death and disability in developed countries, with smoking accounting for 90% of the risk for developing them. Work by scientists at the European Molecular…
SCIENCE & TECHNOLOGY2009
sciencescience-technology
Scientists identify cholesterol-regulating genes
Scientists at the European Molecular Biology Laboratory (EMBL) and the University of Heidelberg, Germany, have come a step closer to understanding how cholesterol levels are regulated. In a study published today in the journal Cell Metabolism, the researchers identified 20 genes that are involved…
SCIENCE & TECHNOLOGY2009
sciencescience-technology
Recycler protein helps prevent disease
Recycling is important not only on a global scale, but also at the cellular level, since key molecules tend to be available in limited numbers. This means a cell needs to have efficient recycling mechanisms. Researchers at the European Molecular Biology Laboratory (EMBL) and Heidelberg University,…
SCIENCE & TECHNOLOGY2009
sciencescience-technology
Defusing dangerous mutations
Mutations in genes are the basis of evolution, so we owe our existence to them. Most mutations are harmful, however, because they cause cells to build defective proteins. So cells have evolved quality control mechanisms that recognize and counteract genetic mistakes. Now scientists of the Molecular…
SCIENCE & TECHNOLOGY2005
sciencescience-technology
Molecular Medicine Partnership Unit initiates second phase
The first rate research from the Molecular Medicine Partnership Unit (MMPU) is now set to continue for the long-term. The European Molecular Biology Laboratory (EMBL) and the Medical Faculty of University of Heidelberg, who formed the joint venture in 2002, have announced their plans to initiate a…
CONNECTIONSLAB MATTERS2005
connectionslab-matters
No results found